Chemoradiotherapy in esophageal cancer: toxicity is in the eye of the beholder.
Ilson
David H
DH
D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D016629:Esophagectomy / Q000379:methods / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy / Q000009:adverse effects* / Q000379:methods; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis